Skip to content
AnalystLens
Back to ALNYIncome Statement

ALNYLAM PHARMACEUTICALS, INC. Revenue 2008-2025 | ALNY

Annual FY2008–FY2025 · quarterly through Q4 FY2025

Latest annual · FY2025

$3.71B

+65.2%YoY vs FY2024Source: 10-KFY2025

From $96.2M in FY2008 to $3.71B in FY2025: 38.6× in 17 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY25$594M+20.2%$774M+17.3%$1.2B+149.3%$1.1B+84.9%
FY24$494M+54.8%$660M+107.0%$501M−33.3%$593M+34.9%
FY23$319M+49.7%$319M+41.8%$751M+184.0%$440M+31.2%
FY22$213M+20.1%$225M+1.9%$264M+40.9%$335M+29.6%
FY21$178M+78.5%$221M+112.1%$188M+49.1%$259M+58.1%
Share19%22%28%31%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionGrowing
CAGR

+49.8%

FY2020
$492.9M
FY2025
$3.71B

5 years selected · on the chart

01—History

Revenue History

Year-over-year comparison from 10-K annual reports

  13. $3.71B
YoY changeLargest recent move+124.3%in FY20Latest +65.2%

1 older move runs past ±150% (largest +7477.6%); point at, tap or drag across the bars to read one.

02—Ledger

Revenue, period by period

PeriodValueChangeSource
FY2025$3.71B+65.2%10-K
FY2024$2.25B+23.0%10-K
FY2023$1.83B+76.2%10-K
FY2022$1.04B+22.9%10-K
FY2021$844.3M+71.3%10-K
FY2020$492.9M+124.3%10-K
FY2019$219.8M+7477.6%10-K
FY2018$2.9M−96.8%10-K
FY2017$89.9M+90.7%10-K
FY2016$47.2M−52.9%10-K
FY2010$100.0M−0.5%10-K
FY2009$100.5M+4.5%10-K
FY2008$96.2M—10-K

03—Questions

What is revenue?

Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

What is ALNYLAM PHARMACEUTICALS, INC.'s current revenue?

ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual revenue for 2025 was $3.71B, a 65.19% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. revenue for the quarter ending December 31, 2025 was $1.10B.

What was ALNYLAM PHARMACEUTICALS, INC.'s revenue in 2024?

ALNYLAM PHARMACEUTICALS, INC. annual revenue for 2024 was $2.25B, a 22.97% increase from 2023.

What was ALNYLAM PHARMACEUTICALS, INC.'s revenue in 2023?

ALNYLAM PHARMACEUTICALS, INC. annual revenue for 2023 was $1.83B, a 76.23% increase from 2022.

What is ALNYLAM PHARMACEUTICALS, INC.'s 5-year revenue CAGR?

ALNYLAM PHARMACEUTICALS, INC. revenue grew at a compound annual growth rate (CAGR) of 49.77% from FY2020 to FY2025, going from $492.9M to $3.71B over 5 years.

Company
ALNYLAM PHARMACEUTICALS, INC.
Ticker
ALNY
Sector
Healthcare
Industry
Pharmaceutical Preparations
View company profile →